Scientific article

Edaravone derivatives containing NO-donor functions

Published inJournal of medicinal chemistry, vol. 52, no. 2, p. 574-578
Publication date2009

A new series of polyvalent drugs obtained by joining edaravone with NO-donor moieties is described. All compounds display high antioxidant power together with NO-dependent vasodilator properties. The analysis of a number of molecular descriptors shows that the antioxidant activity, which is tightly linked to the presence of the edaravone substructure, is principally modulated by lipophilicity. These products are potentially useful in the treatment of cardiovascular disorders in which EDRF deficiency and ROS excess are involved.

  • Antioxidants/chemistry/pharmacology
  • Antipyrine/analogs & derivatives/chemistry/pharmacology
  • Nitric Oxide Donors/chemistry/pharmacology
  • Vasodilator Agents/chemistry/pharmacology
Citation (ISO format)
CHEGAEV, Konstantin et al. Edaravone derivatives containing NO-donor functions. In: Journal of medicinal chemistry, 2009, vol. 52, n° 2, p. 574–578. doi: 10.1021/jm8007008
Main files (1)
Article (Published version)
ISSN of the journal1520-4804

Technical informations

Creation11/05/2009 12:03:00 PM
First validation11/05/2009 12:03:00 PM
Update time03/14/2023 3:17:14 PM
Status update03/14/2023 3:17:14 PM
Last indexation01/15/2024 7:10:50 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack